Their research revealed a distinct pattern wherein patients with relapsed/refractory AML exhibited the highest levels of HOTAIR expression alongside the lowest expression of PTEN, followed by newly diagnosed AML patients and subsequently healthy controls. This evidence concerns the gene HOTAIR and acute myeloid leukemia.